William R Enquist insider trades: Ra Medical Systems (RMED) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where William reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 19, 2020 | RMED | ↑ Buy | 5,263 | $5.82 | $31K | Indirect | Nov 23, 2020 (4d) |
| May 29, 2020 | RMED | ↑ Buy | 50,000 | $0.47 | $24K | Direct | Jun 1, 2020 (3d) |
| Mar 10, 2016 | GI | ↑ Buy | 10,000 | $4.74 | $47K | Direct | Mar 10, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About William R Enquist's insider trades
William R Enquist is a director at Ra Medical Systems (RMED). Since Mar 10, 2016, William has reported 3 open-market purchases worth $102K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.